Analysis of evidence on nutraceutical interventions for Peyronie’s disease: a guideline-based critical review

Author:

Tienforti Daniele12,Hoxha Malvina34,Di Pasquale Alfonso Boris56,Rizza Vinicio7,Barbonetti Arcangelo12

Affiliation:

1. Andrology Unit , Department of Clinical Medicine, Life, Health and Environmental Sciences, , 67100 Coppito, L'Aquila , Italy

2. University of L'Aquila , Department of Clinical Medicine, Life, Health and Environmental Sciences, , 67100 Coppito, L'Aquila , Italy

3. Department for Chemical-Toxicological and Pharmacological Evaluation of Drugs , Faculty of Pharmacy, , 1000 Tirana , Albania

4. Catholic University Our Lady of Good Counsel , Faculty of Pharmacy, , 1000 Tirana , Albania

5. Urology Unit , Department of Urology, , 67100 Coppito, L’Aquila, Italy

6. S. Salvatore Hospital , Department of Urology, , 67100 Coppito, L’Aquila, Italy

7. General Surgery Unit, Surgical Department, S.S. Maria Dello Splendore Hospital , 64021 Giulianova (TE) , Italy

Abstract

Abstract Introduction The management of Peyronie's disease (PD) is a challenge for the clinician. Despite the lack of etiologic therapy, different nonsurgical approaches have often been empirically proposed. The most used treatment is based on nutraceutical drugs with antioxidant activity, although such an intervention remains controversial. Objectives We reviewed the evidence from the randomized controlled trials included in the recommendations of the American Urological Association (AUA), Canadian Urological Association (CUA), European Association of Urology, and International Society for Sexual Medicine. Methods We searched PubMed, Scopus, Web of Science, and Cochrane Library for randomized controlled trials, reviews, and guidelines on nutraceutical interventions for PD. Results Our analysis provides detailed information on potential interventions, underlying the inconsistent evidence. Acetyl esters of carnitine, although not recommended by any of the available guidelines, showed potential benefit in some selected studies. Omega-3 fatty acids are not recommended due to withdrawn study evidence. The CUA and AUA were the only societies to consider the use of coenzyme Q10. While the CUA suggested that it might be offered as a treatment option, the AUA refrained from taking a definitive stance due to insufficient evidence. Similarly, conflicting recommendations have been produced on potassium para-aminobenzoate. While the CUA considers potassium para-aminobenzoate potentially useful in slowing PD progression, the AUA deems the evidence insufficient. Conversely, both the International Society for Sexual Medicine and European Association of Urology do not recommend its use. Conclusion This critical comparative analysis of the most recent guidelines produced by the leading scientific societies highlights some inconsistencies in the recommendations on nutraceutical intervention for PD, even within a background of overall ineffectiveness of this treatment approach.

Publisher

Oxford University Press (OUP)

Reference52 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3